logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

Cheating the admissions system

20 December 2013

Research by the Sutton Trust has highlighted the lengths some parents will go to in order to secure a place at the school of their choice.

It comes as no surprise that parents are stretching the admissions process as much as possible to ensure their child gets into the best school. This negatively impacts upon all schools’ attempts to improve social mobility.

The cause? Perhaps the admissions process is not fit for purpose. As well as hampering social mobility and potentially favouring those with the resources to fully exploit the system, the appeals process offers an unfettered right of appeal that over 80,000 parents exercised in 2011-12 alone. This appeals process offers no consistency between schools and forces schools and local authorities to divert significant resources – senior staff and budget – to arrange and attend the appeals.

This report is perhaps further evidence that a complete overhaul of the admissions and appeals process is required.

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up